Excel Diagnostics & Nuclear Oncology Center

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, epithelial neoplasm, glioblastoma, glioma, malignant endocrine neoplasm, neoplasm, nervous system disorder, neuroepithelial neoplasm, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 1	2026-08-07	NCT07733674
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 3	2026-08-07	NCT03049189
Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 2	2025-05-15	NCT06972628

Clinical trials